Further analyses of the expression data from 533 tumors of the TCGA ccRCC cohort indicated that indeed 88% of all ccRCC tumors showed an OCT2 expression, which was higher than the median gene expression of all genes expressed in ccRCC (Supplementary Fig. S9A). Here, SLC22A2 is linked to nonpapillary renal cell carcinoma.